METHOD FOR PNEUMOUSTIC PNEUMONIA PREVENTION IN HEART RECIPIENTS IN EARLY POSTOPERATIVE PERIOD AFTER HEART TRANSPLANTATION

• 收藏
• 分享

专利权人:

federalnoe gosudarstvennoe byudzhetnoe uchrezhdenie "Federalnyj nauchnyj tsentr transplantologii i iskusstvennykh organov imeni akademika V.I. Shumakova" Ministerstva zdravookhraneniya Rossijskoj Federatsii

发明人:

Gabrielyan Nina Indzarovna,Poptsov Vitalij Nikolaevich,Spirina Ekaterina Aleksandrovna,Krupenio Tatyana Vladimirovna,Kormilitsina Viktoriya Georgievna

申请号：

RU20160111381

公开号：

RU2620016(C1)

申请日:

2016.03.28

申请国别(地区):

俄罗斯

年份:

2017

代理人:

摘要：

FIELD: medicine.SUBSTANCE: recipients are isolated who have been exposed to extracorporal membrane oxygenation technology for at least 24 hours and/or at least two of the following conditions have been identified: gram negative bacteremia after surgery, intraoperative blood loss of more than 500 ml, mechanical ventilation duration of more than 12 hours in the postoperative period. Such patients receive drug or drugs having a bactericidal or bacteriostatic activity against Pneumocystis jiroveci starting from 2-3 days after the operation, for 5-6 days intravenously at a therapeutic dose.EFFECT: reduced toxic effect of multicomponent drug therapy as a result of a differentiated approach to administration of toxic and active agents against pneumocystis.2 cl, 4 ex

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/